title: Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease: Is Stroke Prevention Worth the Risk?
authors.affiliation: University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, England.
authors.forename: Farhan
authors.initials: F
authors.lastname: Shahid
authors.affiliation: University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, England.
authors.forename: Eduard
authors.initials: E
authors.lastname: Shantsila
authors.affiliation: University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, England; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: g.y.h.lip@bham.ac.uk.
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy*; D006801:Humans; D051436:Renal Insufficiency, Chronic; D012306:Risk; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D014859:Warfarin